Status:
UNKNOWN
Evaluating Adrenal Insufficiency in Adults With Eosinophilic Esophagitis on Chronic Swallowed Topical Steroids
Lead Sponsor:
University of Colorado, Denver
Conditions:
Eosinophilic Esophagitis
Eligibility:
All Genders
18-85 years
Brief Summary
Eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus, is a clinical and financial burden to patients if left untreated. Often the natural history of the disease includes dev...
Eligibility Criteria
Inclusion
- 300 adult male or female patients between 18 and 85 years of age with a diagnosis of eosinophilic esophagitis who have been on swallowed topical steroids or proton pump inhibitor therapy (any dosing) for at least 3 months.
Exclusion
- We will exclude control patients on proton pump inhibitor therapy if they have used any form of exogenous steroids within the past one year.
Key Trial Info
Start Date :
August 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05246085
Start Date
August 10 2022
End Date
July 1 2023
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz
Aurora, Colorado, United States, 80045